更年期ほてりの世界市場レポート 2025年

更年期ほてり市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率（CAGR）6.3％で203億7,000万米ドルに成長します。予測期間の成長は、非ホルモン療法の進歩、個別化された治療アプローチ、自然療法への注目、神経伝達経路の調査などに起因すると考えられます。予測期間における主な動向には、非薬理学的介入、デジタルヘルスソリューション、新規薬剤製剤、更年期における精密医療、併用療法などがあります。

更年期の女性の健康に対する政府の取り組みは、今後更年期ほてり市場の成長を促進すると予想されます。更年期の健康に対する政府の取り組みには、更年期の移行を理解し病気を回避するための新規研究への資金提供や、薬理学的、臨床的、疫学的側面と予防研究の関連調査への支援が含まれます。女性の健康に対する政府の取り組みは、更年期の健康やほてりなどの症状の管理、危険因子の研究、予防、重要な健康状態の早期診断による健康増進への取り組みなど、多種多様な関心事を対象としていることが多いです。例えば、2023年1月、オーストラリアの政府機関であるニューサウスウェールズ州政府によると、政府は4年間（2022-2023年から2025-2026年まで）で4,030万米ドルを投じて、深刻な更年期症状に直面する女性のために最大16の新たなプログラムを構築することを開始しました。したがって、更年期の女性の健康に対する政府の取り組みが更年期ほてり市場の成長を促進しています。

ヘルスケア支出の増加は、今後の更年期ほてり市場の成長を促進すると予測されています。ヘルスケア支出とは、特定の期間におけるヘルスケア商品およびサービスに対する総支出のことで、通常は国または地域レベルです。ヘルスケアへの投資が増加することで、先進的な治療オプション、更年期症状に対する認識の向上、調査イニシアチブの強化、ヘルスケアサービスへのアクセス改善、代替療法、サポートプログラムの充実などが期待できます。これは、より効果的な治療や支援ケアサービスを提供することで、更年期ほてりを経験している女性の生活の質を大幅に改善することができます。例えば、2023年5月、英国の政府機関である国家統計局の報告書によると、英国のヘルスケア支出は2022年の0.9％増に対し、2022年から2023年にかけて5.6％増となったことが明らかになった。英国のヘルスケア支出総額は、2023年には約3,176億3,000万米ドル（2,920億英ポンド）に達します。したがって、ヘルスケア支出の拡大が更年期ほてり市場の拡大に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界更年期ほてりPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の更年期ほてり市場：成長率分析
• 世界の更年期ほてり市場の実績：規模と成長, 2019-2024
• 世界の更年期ほてり市場の予測：規模と成長, 2024-2029, 2034F
• 世界更年期ほてり総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の更年期ほてり市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ホルモン治療
• 非ホルモン治療
• 代替治療
• 世界の更年期ほてり市場パイプライン分析、実績と予測, 2019-2024, 2024-2029F, 2034F
• フェーズIIIの医薬品
• フェーズIおよびIIの薬剤
• 世界の更年期ほてり市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小売薬局
• オンライン薬局
• 病院薬局
• 世界の更年期ほてり市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 51～55歳の女性
• 46～50歳の女性
• 40～45歳の女性
• 世界の更年期ほてり市場、ホルモン治療のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• エストロゲン療法
• 複合ホルモン療法
• 世界の更年期ほてり市場、非ホルモン治療のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 選択的セロトニン再取り込み阻害剤
• ガバペンチノイド
• クロニジン
• 世界の更年期ほてり市場、代替治療のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ハーブサプリメント
• 鍼
• ライフスタイルの変更

第7章 地域別・国別分析

• 世界の更年期ほてり市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の更年期ほてり市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 更年期ほてり市場：競合情勢
• 更年期ほてり市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • The Procter & Gamble Company Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• AstraZeneca plc
• GlaxoSmithKline plc.
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Co Ltd.
• Boehringer Ingelheim International GmbH
• Teva Pharmaceutical Industries Ltd.
• Astellas Pharma Inc.
• Eisai Co. Ltd.
• Otsuka Pharmaceutical Co. Ltd.
• Shionogi & Co. Ltd.
• Gedeon Richter Plc
• Lupin Limited
• Hisamitsu Pharmaceutical Co. Inc.
• Noven Pharmaceuticals Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 更年期ほてり市場2029：新たな機会を提供する国
• 更年期ほてり市場2029：新たな機会を提供するセグメント
• 更年期ほてり市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Menopausal hot flashes, also known as vasomotor symptoms, are common experiences during menopause and perimenopause. These symptoms manifest as intense bursts of heat, sweating, and heated skin in women. Hot flashes can be bothersome, causing discomfort, anxiety, and disruption of sleep.

The main types of treatment for menopausal hot flashes encompass hormonal treatment, non-hormonal treatment, and alternative treatment. Hormonal treatment involves therapy for women during the menopausal period when the body ceases to produce estrogen. This therapy typically includes the administration of medications containing female hormones to replace the declining estrogen levels. Pipeline analysis in this context involves the examination of drugs in different phases of development, including phase III drugs and phase I and II drugs. These treatments are typically made available through various distribution channels, such as retail pharmacies, online pharmacies, and hospital pharmacies. The applications of these treatments can be tailored to different age groups, including 51-55-year-old women, 46-50-year-old women, and 40-45-year-old women, depending on individual needs and circumstances.

The menopausal hot flashes market research report is one of a series of new reports from The Business Research Company that provides menopausal hot flashes market statistics, including menopausal hot flashes industry global market size, regional shares, competitors with menopausal hot flashes market share, detailed menopausal hot flashes market segments, market trends, and opportunities, and any further data you may need to thrive in the menopausal hot flashes industry. This menopausal hot flashes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The menopausal hot flashes market size has grown strongly in recent years. It will grow from $15.08 billion in 2024 to $15.98 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to hormone replacement therapy, limited treatment options, awareness and education, shift in lifestyle management, alternative therapies:

The menopausal hot flashes market size is expected to see strong growth in the next few years. It will grow to $20.37 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to advancements in non-hormonal therapies, individualized treatment approaches, focus on natural remedies, research on neurotransmitter pathways. Major trends in the forecast period include non-pharmacological interventions, digital health solutions, novel drug formulations, precision medicine in menopause, combination therapies.

The government's initiatives for women's health in menopause are expected to propel the growth of the menopausal hot flashes market going forward. The government's menopausal health initiatives include financing for novel studies to understand the menopausal transition and avoid illness and support for investigations of linked pharmacological, clinical, and epidemiological aspects and preventive research. Government initiatives for women's health frequently cover a wide variety of concerns, such as menopause health and the management of symptoms such as hot flashes, as well as efforts to promote health through risk factor research, prevention, and early diagnosis of significant health conditions. For instance, in January 2023, according to the Government of New South Wales, an Australia-based government agency, the government initiated $40.3 million over four years (2022-2023 to 2025-2026) to build up to 16 new programs for women facing severe menopausal symptoms. Therefore, the government's initiatives for women's health in menopause are driving the growth of the menopausal hot flashes market.

The rising healthcare expenditure is anticipated to drive the growth of the menopausal hot flashes market in the future. Healthcare expenditure refers to the total spending on healthcare goods and services over a specific period, usually at a national or regional level. Increased investment in healthcare can result in advanced treatment options, greater awareness of menopausal symptoms, enhanced research initiatives, improved access to healthcare services, alternative therapies, and better support programs. This can significantly improve the quality of life for women experiencing menopausal hot flashes by offering more effective treatments and supportive care services. For example, in May 2023, a report by the Office for National Statistics, a UK-based government department, revealed that healthcare spending in the UK increased by 5.6% from 2022 to 2023, compared to 0.9% growth in 2022. The total UK healthcare expenditure reached approximately $317.63 billion (£292 billion) in 2023. Therefore, the growing healthcare expenditure is contributing to the expansion of the menopausal hot flashes market.

The menopausal hot flashes market witnesses a rising inclination towards product innovations, constituting a significant trend. Notably, prominent entities within this market are actively introducing inventive solutions to fortify their market standing. An instance of this was observed in May 2023 when Astellas Pharma US Inc., a US-based pharmaceutical establishment, announced the FDA's approval of Veozah. This novel treatment, designed for menopause-induced hot flashes, marks the pioneering approval of a neurokinin 3 (NK3) receptor inhibitor for managing mild to severe hot flashes related to menopause. Its mechanism involves binding to and activating the NK3 receptor, integral in regulating body temperature within the brain.

Major industry players are strategically forging alliances to drive new product development initiatives and bolster their market presence. Such collaborations and partnerships in this domain serve to stimulate innovation, harness synergistic expertise, and expedite the progression and commercial launch of advanced therapies. For instance, in July 2022, Lisa Health Inc., a US-based digital health entity, entered a collaborative venture with Mayo Clinic, a US-based academic medical institution, to introduce 'Midday.' This app-based innovation caters to personalized menopausal management through the integration of digital therapeutics and artificial intelligence (AI). By leveraging intricate algorithms and sensor technology customized to individual stages and symptoms, Midday endeavors to address gaps in care, offering tailored guidance, educational resources, and strategies. Additionally, Midday provides users access to Mayo Clinic's technology platform, facilitating education on menopausal hormone treatment and aiding users in making informed decisions regarding its suitability.

In October 2022, Unified Women's Healthcare, a prominent US-based healthcare company specializing in women's healthcare treatment, successfully acquired Gennev for an undisclosed amount. Through this strategic acquisition, Unified Women's Healthcare aims to broaden its women's healthcare portfolio, with the objective of enhancing outcomes and the overall patient experience at every stage of a woman's healthcare journey. Gennev, the acquired company, is based in the United States and provides feminine care services, offering various treatments to empower women to take control of their health throughout and after the menopausal transition.

Major companies operating in the menopausal hot flashes market include Pfizer Inc., Johnson & Johnson, The Procter & Gamble Company, Merck & Co. Inc., Bayer AG, Novartis AG, AstraZeneca plc, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Eisai Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Shionogi & Co. Ltd., Gedeon Richter Plc, Lupin Limited, Hisamitsu Pharmaceutical Co. Inc., Noven Pharmaceuticals Inc., Ligand Pharmaceuticals Inc., Mithra Pharmaceuticals SA, TherapeuticsMD Inc., Theramex Ltd., Ascend Therapeutics Inc., EndoCeutics Inc., Sermonix Pharmaceuticals LLC, Ralington pharma LLP

North America was the largest region in the Menopausal Hot Flashes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the menopausal hot flashes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the menopausal hot flashes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The menopausal hot flashes market consists of revenues earned by entities by providing estrogen therapy, and menopause hormone therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The menopausal hot flashes market also includes sales of venlafaxine, paroxetine, and escitalopram. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Menopausal Hot Flashes Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on menopausal hot flashes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for menopausal hot flashes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The menopausal hot flashes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Hormonal Treatment; Non-Hormonal Treatment; Alternative Treatment
• 2) By Pipeline Analysis: Phase III Drugs; Phase I And II Drugs
• 3) By Distribution Channel: Retail Pharmacies; Online Pharmacies; Hospital Pharmacies
• 4) By Application: 51-55 Year Old Woman; 46-50 Year Old Woman; 40-45 Year Old Woman
• Subsegments:
• 1) By Hormonal Treatment: Estrogen Therapy; Combined Hormonal Therapy
• 2) By Non-Hormonal Treatment: Selective Serotonin Reuptake Inhibitors; Gabapentinoids; Clonidine
• 3) By Alternative Treatment: Herbal Supplements; Acupuncture; Lifestyle Modifications
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; The Procter & Gamble Company; Merck & Co. Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Menopausal Hot Flashes Market Characteristics

3. Menopausal Hot Flashes Market Trends And Strategies

4. Menopausal Hot Flashes Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Menopausal Hot Flashes Growth Analysis And Strategic Analysis Framework

• 5.1. Global Menopausal Hot Flashes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Menopausal Hot Flashes Market Growth Rate Analysis
• 5.4. Global Menopausal Hot Flashes Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Menopausal Hot Flashes Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Menopausal Hot Flashes Total Addressable Market (TAM)

6. Menopausal Hot Flashes Market Segmentation

• 6.1. Global Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hormonal Treatment
• Non-Hormonal Treatment
• Alternative Treatment
• 6.2. Global Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Phase III Drugs
• Phase I And II Drugs
• 6.3. Global Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retail Pharmacies
• Online Pharmacies
• Hospital Pharmacies
• 6.4. Global Menopausal Hot Flashes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 51-55 Year Old Woman
• 46-50 Year Old Woman
• 40-45 Year Old Woman
• 6.5. Global Menopausal Hot Flashes Market, Sub-Segmentation Of Hormonal Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Estrogen Therapy
• Combined Hormonal Therapy
• 6.6. Global Menopausal Hot Flashes Market, Sub-Segmentation Of Non-Hormonal Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Selective Serotonin Reuptake Inhibitors
• Gabapentinoids
• Clonidine
• 6.7. Global Menopausal Hot Flashes Market, Sub-Segmentation Of Alternative Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Herbal Supplements
• Acupuncture
• Lifestyle Modifications

7. Menopausal Hot Flashes Market Regional And Country Analysis

• 7.1. Global Menopausal Hot Flashes Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Menopausal Hot Flashes Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Menopausal Hot Flashes Market

• 8.1. Asia-Pacific Menopausal Hot Flashes Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Menopausal Hot Flashes Market

• 9.1. China Menopausal Hot Flashes Market Overview
• 9.2. China Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Menopausal Hot Flashes Market

• 10.1. India Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Menopausal Hot Flashes Market

• 11.1. Japan Menopausal Hot Flashes Market Overview
• 11.2. Japan Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Menopausal Hot Flashes Market

• 12.1. Australia Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Menopausal Hot Flashes Market

• 13.1. Indonesia Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Menopausal Hot Flashes Market

• 14.1. South Korea Menopausal Hot Flashes Market Overview
• 14.2. South Korea Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Menopausal Hot Flashes Market

• 15.1. Western Europe Menopausal Hot Flashes Market Overview
• 15.2. Western Europe Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Menopausal Hot Flashes Market

• 16.1. UK Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Menopausal Hot Flashes Market

• 17.1. Germany Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Menopausal Hot Flashes Market

• 18.1. France Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Menopausal Hot Flashes Market

• 19.1. Italy Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Menopausal Hot Flashes Market

• 20.1. Spain Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Menopausal Hot Flashes Market

• 21.1. Eastern Europe Menopausal Hot Flashes Market Overview
• 21.2. Eastern Europe Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Menopausal Hot Flashes Market

• 22.1. Russia Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Menopausal Hot Flashes Market

• 23.1. North America Menopausal Hot Flashes Market Overview
• 23.2. North America Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Menopausal Hot Flashes Market

• 24.1. USA Menopausal Hot Flashes Market Overview
• 24.2. USA Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Menopausal Hot Flashes Market

• 25.1. Canada Menopausal Hot Flashes Market Overview
• 25.2. Canada Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Menopausal Hot Flashes Market

• 26.1. South America Menopausal Hot Flashes Market Overview
• 26.2. South America Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Menopausal Hot Flashes Market

• 27.1. Brazil Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Menopausal Hot Flashes Market

• 28.1. Middle East Menopausal Hot Flashes Market Overview
• 28.2. Middle East Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Menopausal Hot Flashes Market

• 29.1. Africa Menopausal Hot Flashes Market Overview
• 29.2. Africa Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Menopausal Hot Flashes Market Competitive Landscape And Company Profiles

• 30.1. Menopausal Hot Flashes Market Competitive Landscape
• 30.2. Menopausal Hot Flashes Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. The Procter & Gamble Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Menopausal Hot Flashes Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. AstraZeneca plc
• 31.3. GlaxoSmithKline plc.
• 31.4. Takeda Pharmaceutical Company Limited
• 31.5. Eli Lilly and Co Ltd.
• 31.6. Boehringer Ingelheim International GmbH
• 31.7. Teva Pharmaceutical Industries Ltd.
• 31.8. Astellas Pharma Inc.
• 31.9. Eisai Co. Ltd.
• 31.10. Otsuka Pharmaceutical Co. Ltd.
• 31.11. Shionogi & Co. Ltd.
• 31.12. Gedeon Richter Plc
• 31.13. Lupin Limited
• 31.14. Hisamitsu Pharmaceutical Co. Inc.
• 31.15. Noven Pharmaceuticals Inc.

32. Global Menopausal Hot Flashes Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Menopausal Hot Flashes Market

34. Recent Developments In The Menopausal Hot Flashes Market

35. Menopausal Hot Flashes Market High Potential Countries, Segments and Strategies

• 35.1 Menopausal Hot Flashes Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Menopausal Hot Flashes Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Menopausal Hot Flashes Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer